0.25
price down icon15.17%   -0.0447
after-market Handel nachbörslich: .26 0.01 +4.00%
loading

Finanzdaten der Plus Therapeutics Inc-Aktie (PSTV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
0.50%
1.397
1.39 1.059 1.412 1.456
Operating Expenses
100.79%
5.879
2.928 4.595 5.312 5.255
Benefits Costs and Expenses
-
- - -13.49 4.33
Costs And Expenses
100.79%
5.879
2.928 4.595 5.312 5.255
Operating Income/Loss
191.42%
-4.482
-1.538 -3.536 -3.90 -3.799
Nonoperating Income/Loss
99.12%
0.059
6.689 -13.87 -0.003 0.925
Income/Loss From Continuing Operations Before Tax
72.88%
1.397
5.151 -17.40 14.90 -2.874
Income/Loss From Continuing Operations After Tax
185.87%
-4.423
5.151 -17.40 -3.903 -2.874
Net Income/Loss
185.87%
-4.423
5.151 -17.40 -3.903 -2.874
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
122.01%
107.43
48.39 14.57 0.4081 7.8558
Diluted Average Shares
48.64%
107.43
209.15 14.57 -0.7516 7.8558
Basic Earnings Per Share
300.00%
-0.04
0.02 -1.19 -0.49 -0.37
Diluted Earnings Per Share
300.00%
-0.04
-0.01 -1.19 -0.67 -0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):